David A Rizzieri (David Rizzieri)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Cognitive Impairment

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Guillermo Garcia Manero, Nikolai A Podoltsev, Megan K D Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litzow, M Lynn Savoie, Bruno C Medeiros, Mikkael A Sekeres, Tara L Lin, Geoffrey L Uy, Bayard L Powell, Jonathan E Kolitz, Richard A Larson, Richard M Stone, David F Claxton, James Essell, Selina M Luger, Sanjay R Mohan, Anna B Moseley, Frederick R Appelbaum, Harry P Erba
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. Leukemia (2023)
Naveen Pemmaraju, Hagop M Kantarjian, Kendra L Sweet, Eunice S Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Y Konopleva, Arthur E Frankel, Vikas K Gupta, Ruben A Mesa, Matthew L Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James R Mason, Maria Teresa García-Romero, Norma C Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland Bruno Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K Rampal, Marcos de Lima, James M Foran, Amir T Fathi, Aric C Hall, Meagan A Jacoby, Jeffrey E Lancet, Gabriel N Mannis, Anthony S Stein, Alice S Mims, David A Rizzieri, Rebecca L Olin, Alexander E Perl, Gary J Schiller, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew J Wieduwilt, Naval G Daver, Farhad Ravandi, Sumithira Vasu, Monica L Guzman, Gail J Roboz, Joseph D Khoury, Muzaffar H Qazilbash, Leomar Y Ballester, Branko Cuglievan, Yazan F Madanat, Mohamed A Kharfan-Dabaja, Anna B Pawlowska, Justin Taylor, Martin S Tallman, Prajwal Dhakal, Andrew A Lane
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood (2022)
Kevin H Lin, Justine C Rutter, Abigail Xie, Shane T Killarney, Camille Vaganay, Chaima Benaksas, Frank Ling, Gaetano Sodaro, Paul-Arthur Meslin, Christopher F Bassil, Nina Fenouille, Jacob P Hoj, Rachel Washart, Hazel X Ang, Christian G Cerda-Smith, Paul Chaintreuil, Arnaud Jacquel, Patrick Auberger, Antoine Forget, Raphaël A Itzykson, Min Lu, Jiaxing Lin, Mariaelena Pierobon, Zhecheng Sheng, Xinghai Li, Ashutosh Chilkoti, Kouros Owzar, David A Rizzieri, Timothy S Pardee, Lina Benajiba, Emanuel Petricoin, Alexandre Puissant, Kris C Wood
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia. Nature cancer 3 (7) (2022)
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher N Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, Christopher G Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell M Krem, Hillard M Lazarus, Hongtao Liu, Rodrigo Martino Bofarull, Fotios V Michelis, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Ran Reshef, David A Rizzieri, Jacob M Rowe, Bipin P Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F Verdonck, Christopher S Hourigan, Brenda M Sandmaier, Mark R Litzow, Partow Kebriaei, Daniel J Weisdorf, Yanming Zhang, Martin S Tallman, Wael Saber
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances (2021)
Hagop M Kantarjian, Kebede H Begna, Jessica K Altman, Stuart L Goldberg, Mikkael A Sekeres, Stephen A Strickland, Martha L Arellano, David F Claxton, Maria R Baer, Marc Gautier, Ellin Berman, Karen Seiter, Scott R Solomon, Gary J Schiller, Selina M Luger, Aleksandra Butrym, Gianluca Gaidano, Xavier G Thomas, Pau Montesinos, David A Rizzieri, Donald P Quick, Parameswaran Venugopal, Rakesh Gaur, Lori J Maness, Tapan Mahendra Kadia, Farhad Ravandi, Marc E Buyse, Judy H Chiao
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer 127 (23) (2021)
Matthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, David I Marks, A Samar Al-Homsi, Lori S Muffly, Nelson J Chao, David A Rizzieri, Robert Peter Gale, Shahinaz M Gadalla, Mitchell S Cairo, Alberto Mussetti, Steven D Gore, Vijaya Raj Bhatt, Sagar S Patel, Fotios V Michelis, Yoshihiro Inamoto, Sherif M Badawy, Edward Copelan, Neil Palmisiano, Mohamed A Kharfan-Dabaja, Hillard M Lazarus, Siddhartha Ganguly, Christopher N Bredeson, Miguel Angel Diaz Perez, Ryan Cassaday, Bipin P Savani, Karen Kuhn Ballen, Rodrigo Martino Bofarull, Baldeep Wirk, Vera Ulrike Bacher, Mahmoud Aljurf, Asad Bashey, Hemant S Murthy, Jean A Yared, Ibrahim Aldoss, Nosha Farhadfar, Hongtao Liu, Hisham Abdel-Azim, Edmund K Waller, Melhem Solh, Matthew Seftel, Marjolein W M van der Poel, Michael Richard Grunwald, Jane L Liesveld, Rammurti T Kamble, Joseph P McGuirk, Reinhold Munker, Jean-Yves Cahn, Jong Wook Lee, Cesar O Freytes, Maxwell M Krem, Lena E Winestone, Usama Gergis, Sunita Nathan, Richard F Olsson, Leo F Verdonck, Akshay Sharma, Olle Ringdén, Brian D Friend, Jan Cerny, Hannah K Choe, Saurabh Chhabra, Taiga Nishihori, Sachiko Seo, Biju George, Lee Ann Baxter-Lowe, Gerhard Carl Hildebrandt, Marcos J deLima, Mark R Litzow, Partow Kebriaei, Christopher S Hourigan, Muhammad Bilal Abid, Daniel J Weisdorf, Wael Saber
Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood advances (2021)
Mohamed Lotfy Sorror, Barry E Storer, Amir T Fathi, Andrew Brunner, Aaron T Gerds, Mikkael A Sekeres, Sudipto Mukherjee, Bruno C Medeiros, Eunice S Wang, Pankit Vachhani, Paul J Shami, Esteban Peña, Mahmoud Elsawy, Kehinde U A Adekola, Selina Luger, Maria R Baer, David A Rizzieri, Tanya M Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Wendy M Leisenring, Lynn Onstad, Jennifer E Nyland, Pamela S Becker, Jeannine S McCune, Stephanie J Lee, Brenda M Sandmaier, Frederick R Appelbaum, Elihu H Estey
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. Blood 138 (5) (2021)
Patrick J Smith, Meagan Lew, Yen Lowder, Kristi Romero, Jillian C Thompson, Lauren Bohannon, Alyssa Pittman, Alexandra Artica, Sendhilnathan Ramalingam, Taewoong Choi, Cristina Gasparetto, Mitchell E Horwitz, Gwynn Long, Richard Lopez, David A Rizzieri, Stefanie Sarantopoulos, Keith M Sullivan, Nelson J Chao, Anthony D Sung
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation (2021)
Jesus G Berdeja, Michael C Heinrich, Shaker R Dakhil, Stuart L Goldberg, Martha Wadleigh, Philip Kuriakose, Jorge E Cortes, Jerald Radich, Bret Helton, David A Rizzieri, Carole Paley, Ilva Dautaj, Michael J Mauro
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis. Leukemia & lymphoma 60 (10) (2019)